person · Reporting owner

Picho Diane I.

Disclosed activity across 1 company

Tapewire entity: 82363
SEC CIK: 0002016905

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Chemours CoCC · Entity 4420	See Remarks	March 03, 2025	March 05, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Chemours Co

Report date March 03, 2025 · Filed March 05, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	27,656.4229	Reported balance After 2025-03-03 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2025-03-03 · Grant · Acquired 9,018 · Balance 27,656.4229 F1: Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2026. F2: Includes directly owned shares, RSUs and dividend equivalent units.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.86 · Expires 2035-03-03	Direct	29,976	Reported balance After 2025-03-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-03-03 · Grant · Acquired 29,976 · Balance 29,976 F3: These options are scheduled to vest in three equal annual installments beginning on March 3, 2026.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.25 · Expires 2035-03-03	Direct	31,175	Reported balance After 2025-03-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2025-03-03 · Grant · Acquired 31,175 · Balance 31,175 F4: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. F3: These options are scheduled to vest in three equal annual installments beginning on March 3, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2026.

F2: Includes directly owned shares, RSUs and dividend equivalent units.

F3: These options are scheduled to vest in three equal annual installments beginning on March 3, 2026.

F4: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 03, 2025 Filed Mar 5, 2025 20:47 UTC	Chemours Co CC · Entity 4420	GrantStock Option (Right to Buy) · Derivative	31,175	$0.00 Strike: $15.25	$0.00	Disclosure SEC source: 0001062993-25-004728 · form4.xml · derivative · entry 3 Picho Diane I. · CIK 0002016905 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,175 Underlying: Common Stock · 31,175 shares Expires 2035-03-03 F4 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 3, 2026. Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:47 UTC	Chemours Co CC · Entity 4420	GrantStock Option (Right to Buy) · Derivative	29,976	$0.00 Strike: $13.86	$0.00	Disclosure SEC source: 0001062993-25-004728 · form4.xml · derivative · entry 2 Picho Diane I. · CIK 0002016905 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,976 Underlying: Common Stock · 29,976 shares Expires 2035-03-03 F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 3, 2026. Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:47 UTC	Chemours Co CC · Entity 4420	GrantCommon Stock	9,018	$0.00	$0.00	Disclosure SEC source: 0001062993-25-004728 · form4.xml · nonDerivative · entry 1 Picho Diane I. · CIK 0002016905 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,656.4229 F1 · shares: Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2026. F2 · balance_after: Includes directly owned shares, RSUs and dividend equivalent units. Read SEC document
March 01, 2025 Filed Mar 4, 2025 20:51 UTC	Chemours Co CC · Entity 4420	Tax withholdingCommon Stock	1,252	$14.95	$18,717.40	Disclosure SEC source: 0001062993-25-004445 · form4.xml · nonDerivative · entry 1 Picho Diane I. · CIK 0002016905 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,638.4229 F1 · kind: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document
August 07, 2024 Filed Aug 8, 2024 16:44 UTC	Chemours Co CC · Entity 4420	SaleCommon Stock	1,108	$18.84	$20,874.72	Disclosure SEC source: 0001062993-24-014675 · form4.xml · nonDerivative · entry 3 Picho Diane I. · CIK 0002016905 · Interim Pres. - Titanium Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,890.4229 F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document
August 07, 2024 Filed Aug 8, 2024 16:44 UTC	Chemours Co CC · Entity 4420	SaleCommon Stock	1,576	$18.81	$29,644.56	Disclosure SEC source: 0001062993-24-014675 · form4.xml · nonDerivative · entry 2 Picho Diane I. · CIK 0002016905 · Interim Pres. - Titanium Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,998.4229 F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document
August 06, 2024 Filed Aug 8, 2024 16:44 UTC	Chemours Co CC · Entity 4420	SaleCommon Stock	73	$19.04	$1,389.92	Disclosure SEC source: 0001062993-24-014675 · form4.xml · nonDerivative · entry 1 Picho Diane I. · CIK 0002016905 · Interim Pres. - Titanium Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,574.4229 F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document
May 08, 2024 Filed May 10, 2024 16:05 UTC	Chemours Co CC · Entity 4420	GrantStock Option (Right to Buy) · Derivative	19,455	$0.00 Strike: $27.50	$0.00	Disclosure SEC source: 0001062993-24-009880 · form4.xml · derivative · entry 2 Picho Diane I. · CIK 0002016905 · Interim Pres. - Titanium Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,455 Underlying: Common Stock · 19,455 shares Expires 2034-05-08 F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. Read SEC document
May 08, 2024 Filed May 10, 2024 16:05 UTC	Chemours Co CC · Entity 4420	GrantCommon Stock	7,272	$0.00	$0.00	Disclosure SEC source: 0001062993-24-009880 · form4.xml · nonDerivative · entry 1 Picho Diane I. · CIK 0002016905 · Interim Pres. - Titanium Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,552.9708 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.